Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
AVBP | ArriVent BioPharma, Inc. | General Counsel | $27K | Jan 25, 2024 | ||
SYRE | Spyre Therapeutics, Inc. | General Counsel | Feb 23, 2023 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|